Myobloc

FDA Mandates New Warnings for Botox

... said. "Switching patients from one to another runs the risk of underdosing or, more important, overdosing." The three approved products are Botox, myobloc and Dysport, which was approved this week. Officials said there have been no post-marketing reports of similar problems with the newest drug. The i...

Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles

...ween the brows in people 18 to 65 years of age. In its recent communication, the FDA reports adverse events associated with Botox, Botox Cosmetic, and myobloc and has a continuing review of their safety. Botox is the most common cosmetic procedure, with 4.1 million procedures performed in 2006 according the ...

FDA Warns of Children's Deaths Linked to Botox

... Anti-wrinkle drug and competitor myobloc under agency safety review FRIDAY, Feb...um toxin type A) and Solstice Neurosciences Inc.'s myobloc (botulinum toxin type B) after reports of the adve...er, the FDA's Adverse Event database for Botox and myobloc found 180 adverse events in the United States, inc...

Myobloc in Medical Technology

Solstice Neurosciences Presents Escalating Dose Study at International Congress in Istanbul, Turkey

...pert add to the ever-growing body of evidence that myobloc can safely and effectively be used in a variety of...t International Congress was held in 1990. About myobloc Myobloc(R) (Botulinum Toxin Type B) Injectable S.... The most frequently reported adverse events with myobloc are dry mouth, dysphagia, dyspepsia, and injection...

Myobloc in Medical Products

Myobloc®(Botulinum Toxin Type B) Injectable Solution

Description:... myobloc (Botulinum Toxin Type B) Injectable Solution, the only Botulinum Toxin Type...vered as a purified, ready-to-use solution, in three convenient vial sizes, myobloc offers a simpler way to significantly reduce abnormal head position and nec...
Company:Solstice Neurosciences, Inc.

Myobloc in Biological Technology

Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication

...y additional information needed. About MYOBLOC myobloc was the first drug approved in the US to reduce th...tudies in adult patients with cervical dystonia. myobloc is supplied as a ready-to-use, injectable solution...5,000 U), and 2.0 mL (10,000 U). Unopened vials of myobloc have demonstrated stability when stored at 2-8 deg...

Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.

...only botulinum toxin type B currently available to physicians and patients. myobloc is sold in the United States and approved in Canada. It is also distributed and sold in the EU as NeuroBloc. myobloc is indicated for the treatment of patients with cervical dystonia (CD) to r...

New Online Learning Tool Fills the Knowledge Gap on Botulinum Toxin Type B for Cervical Dystonia

...ing and muscle injection techniques when using myobloc to reduce the severity of abnormal head position a... The most frequently reported adverse events with myobloc are dry mouth, dysphagia, dyspepsia, and injection... also distributed and sold in the EU as NeuroBloc. myobloc is indicated for the treatment of patients with ce...

Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.

...only botulinum toxin type B currently available to physicians and patients. myobloc is sold in the United States and approved in Canada. It is also distributed and sold in the EU as NeuroBloc. myobloc is indicated for the treatment of patients with cervical dystonia (CD) to r...